Medical News

---

• Predictors of distal embolization during renal angioplasty identified
• No harm from relaxed antihypertensive strategy in acute stroke
• Metabolic syndrome increases risk for prostate cancer
• Enzymatic target identified for castration-resistant prostate cancer
• Metabolic syndrome increases risk for prostate cancer
• Enzymatic target identified for castration-resistant prostate cancer
• Aggregate tumor size of every focus important in multifocal breast tumors
• PLTP variants linked to reduced vascular risk
• Neutrophils implicated in plaque instability
• Quick-release bromocriptine not linked to adverse CV side effects
• Rosiglitazone linked to increased MI risk in updated meta-analysis
• Benefit of telephone intervention in HF persists for 3 years
• Features of long-QT syndrome shown by human stem cell model
• Aggregate tumor size of every focus important in multifocal breast tumors

Predictors of distal embolization during renal angioplasty identified Posted: 22 Jul 2010 05:00 PM PDT Analysis of patients from the RESIST trial who underwent renal artery angioplasty and stenting has revealed factors that predict distal embolization associated with the procedure.

No harm from relaxed antihypertensive strategy in acute stroke Posted: 22 Jul 2010 05:00 PM PDT Stopping pre-existing antihypertensive treatment for 2 weeks after an acute stroke does not appear to harm patients, show the results of the COSSACS trial.

Metabolic syndrome increases risk for prostate cancer Posted: 22 Jul 2010 05:00 PM PDT Swedish study results show that men with metabolic syndrome are at increased risk for developing prostate cancer, after taking into account their competing risk for early death from other causes associated with having the syndrome.

Enzymatic target identified for castration-resistant prostate cancer Posted: 22 Jul 2010 05:00 PM PDT US researchers have identified an enzyme that they say could be the key to halting progression of advanced prostate cancer that is resistant to ADT.

Metabolic syndrome increases risk for prostate cancer Posted: 22 Jul 2010 05:00 PM PDT Swedish study results show that men with metabolic syndrome are at increased risk for developing prostate cancer, after taking into account their competing risk for early death from other causes associated with having the syndrome.

Enzymatic target identified for castration-resistant prostate cancer Posted: 22 Jul 2010 05:00 PM PDT US researchers have identified an enzyme that they say could be the key to halting progression of advanced prostate cancer that is resistant to ADT.

Aggregate tumor size of every focus important in multifocal breast tumors Posted: 22 Jul 2010 05:00 PM PDT When planning treatment for patients with multifocal breast cancer, the aggregate size of every focus rather than just the largest or dominant tumor size should be considered, Australian research shows.

PLTP variants linked to reduced vascular risk Posted: 22 Jul 2010 05:00 PM PDT People with genetically driven reductions in phospholipid transfer protein activity have increased numbers of small high-density lipoprotein particles and reduced cardiovascular disease risk, research suggests.

Neutrophils implicated in plaque instability Posted: 22 Jul 2010 05:00 PM PDT Neutrophils are most numerous in carotid plaques with features denoting instability, study findings show.

Quick-release bromocriptine not linked to adverse CV side effects Posted: 22 Jul 2010 05:00 PM PDT Quick-release bromocriptine is a well tolerated and effective therapy for Type 2 diabetes and is not associated with increased cardiovascular risk, report researchers.

Rosiglitazone linked to increased MI risk in updated meta-analysis Posted: 22 Jul 2010 05:00 PM PDT Results from an updated meta-analysis published in the Archives of Internal Medicine indicate that rosiglitazone therapy is associated with an increased risk for myocardial infarction, but not cardiovascular mortality.

Benefit of telephone intervention in HF persists for 3 years Posted: 22 Jul 2010 05:00 PM PDT A telephone intervention in patients with heart failure reduces the rate of death and hospitalization, an effect which persists for up to 3 years, report Argentine researchers in the Journal of the American College of Cardiology.

Features of long-QT syndrome shown by human stem cell model Posted: 22 Jul 2010 05:00 PM PDT German researchers report that the electrophysiological features of long-QT syndrome type 1 are reproduced in cardiac myocyte cells differentiated in vitro from stem cells taken from patients with the condition.

Aggregate tumor size of every focus important in multifocal breast tumors Posted: 22 Jul 2010 05:00 PM PDT When planning treatment for patients with multifocal breast cancer, the aggregate size of every focus rather than just the largest or dominant tumor size should be considered, Australian research shows.

You are subscribed to email updates from MedWire Medical News Combined Feed To stop receiving these emails, you may unsubscribe now.	Email delivery powered by Google
Google Inc., 20 West Kinzie, Chicago IL USA 60610